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ARTICLE OPEN
The evolutionary trajectories of P. aeruginosa in biofilm and
planktonic growth modes exposed to ciprofloxacin: beyond
selection of antibiotic resistance
Marwa N. Ahmed1,2, Ahmed Abdelsamad3, Tina Wassermann4, Andreas Porse5, Janna Becker1, Morten O. A. Sommer5,
Niels Høiby1,4 and Oana Ciofu 1✉
Ciprofloxacin (CIP) is used to treat Pseudomonas aeruginosa biofilm infections. We showed that the pathways of CIP-resistance
development during exposure of biofilms and planktonic P. aeruginosa populations to subinhibitory levels of CIP depend on the
mode of growth. In the present study, we analyzed CIP-resistant isolates obtained from previous evolution experiments, and we
report a variety of evolved phenotypic and genotypic changes that occurred in parallel with the evolution of CIP-resistance. Cross-
resistance to beta-lactam antibiotics was associated with mutations in genes involved in cell-wall recycling (ftsZ, murG); and could
also be explained by mutations in the TCA cycle (sdhA) genes and in genes involved in arginine catabolism. We found that CIP-
exposed isolates that lacked mutations in quorum-sensing genes and acquired mutations in type IV pili genes maintained
swarming motility and lost twitching motility, respectively. Evolved CIP-resistant isolates showed high fitness cost in planktonic
competition experiments, yet persisted in the biofilm under control conditions, compared with ancestor isolates and had an
advantage when exposed to CIP. Their persistence in biofilm competition experiments in spite of their fitness cost in planktonic
growth could be explained by their prolonged lag-phase. Interestingly, the set of mutated genes that we identified in these in vitro-
evolved CIP-resistant colonies, overlap with a large number of patho-adaptive genes previously reported in P. aeruginosa isolates
from cystic fibrosis (CF) patients. This suggests that the antibiotic stress is contributing to the bacterial evolution in vivo, and that
adaptive laboratory evolution can be used to predict the in vivo evolutionary trajectories.
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INTRODUCTION
Sublethal concentrations of antibiotics are present in clinical
settings at the infection site in certain tissues as a consequence of
limited accessibility as well as in the environment. It has been
shown that resistant mutants, even with high MICs can be
selected at sublethal antibiotic concentrations1–3. In addition,
antibiotics at sublethal concentrations are responsible for increas-
ing genetic variation4 by means of different pathways involving
oxidative stress5, by inducing error-prone polymerases mediated
by the SOS response6, by misbalancing nucleotide metabolism or
acting directly on DNA7. In this respect, quinolones have been
known for years to be mutagenic in bacteria8. This implies that
antibiotic therapy, in some cases, may have the detrimental side-
effect of accelerating the adaptation of pathogens as well as of the
commensal strains (suggested to be a major reservoir of
resistance).
We have previously reported in a planktonic experimental
evolution study conducted on more than 900 generations of
Pseudomonas aeruginosa, that high-level CIP-resistant mutants
with cross-resistance to beta-lactams developed quickly in the
presence of a subinhibitory concentration of ciprofloxacin9, and a
phenotypic shift of the P. aeruginosa populations evolved under
constant exposure to subinhibitory concentrations of CIP10.
Compared to the controls (CTRL), the populations evolved in the
presence of sublethal concentrations of CIP showed decreased
protease activity and swimming motility, higher levels of quorum-
sensing (QS) signal molecules and upregulation of denitrification
genes10. These observations suggested that evolution in the
presence of sublethal concentrations of CIP has pleiotropic effects
on the bacterial phenotypes and this might promote persistence
of the resistant bacterial population.
Persistent infections are caused by biofilm-embedded bacteria
which are characterized by multifactorial intrinsic tolerance
(phenotypic resistance) to antibiotics11. However, several recent
studies have demonstrated the supplementary role played by
mutational resistance in the survival of biofilms to antibiotic
treatment12,13.
We have recently investigated the evolution of mutational
resistance in P. aeruginosa biofilms exposed to subinhibitory
concentrations of CIP and showed that the biofilm mode of
growth promotes development of low-level mutational resis-
tance14 and that this process was accelerated during evolution of
a P. aeruginosa catalase mutant, as a surrogate of the oxidative
stress environment present at the site of chronic infections15.
The phenotypic shifts that we have previously observed in the
experimental evolution of planktonic cultures exposed to sub-
lethal levels of CIP10 encouraged us to investigate, the phenotypic
and genomic evolution associated with CIP-resistance in bio-
films14,15. The experimental set-up of the investigation of the
phenotypic and genotypic landscape of evolution under exposure
to subinhibitory levels of CIP is presented in Fig. 1.
We show here that prolonged exposure of P. aeruginosa
biofilms to sub-MIC CIP led to mutations which were associated
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with extensive phenotypic changes. Cross-resistance between CIP
and beta-lactam antibiotics such as aztreonam and ceftazidime,
differential swarming and twitching motility compared to CTRL,
growth curves with a prolonged lag phase, and metabolic shifts
toward anaerobic respiration were observed. A fitness cost of CIP
resistance in biofilms was observed in the absence of antibiotics.
However, non-surprisingly, CIP-resistant colonies had increased
fitness when the competition experiments were conducted in the
presence of CIP. Overall, our data show that under antibiotic
stress, mutational resistance to CIP associates with mutations in
several genes that probably play a role in the persistence of
biofilms during antibiotic treatment. Interestingly, the set of
mutated genes that we identified in these in vitro-evolved CIP-
resistant colonies, overlap with a large number of patho-adaptive
genes previously reported in P. aeruginosa isolates from cystic
fibrosis (CF) patients. This is identifying antibiotic stress as an
important environmental factor that shapes the bacterial evolu-
tion in vivo. It can thus be speculated that this, together with the
Fig. 1 Experimental design of the in vitro P. aeruginosa evolution studies and analysis of the evolved isolates. a Experimental evolution in
colony biofilm and stationary-phase planktonic culture. A colony biofilm was formed on polycarbonate membrane from an overnight culture
of P. aeruginosa (WT PAO1 or ΔkatA). In the step called passage 0 (P0), membranes containing 48-h colony biofilms were transferred to fresh LB
plates with either CIP or without CIP for 48 h (CTRL). Every 48 h, the colony biofilms were disrupted, and the bacterial populations were used
to start new biofilms. The bacterial populations of disrupted CIP biofilms were used to start new colony-biofilms on plates with CIP and the
bacterial populations of disrupted CTRL biofilms were used to start new colony-biofilms on LB plates. This was repeated for six passages
(P1–P6). b Evolved biofilm and planktonic populations (CIP and CTRL) were plated on concentrations higher than the minimum inhibitory
concentrations (MIC) of ciprofloxacin. The resistant colonies were collected for phenotypic and genotypic analysis to elucidate the
evolutionary trajectories under exposure to subinhibitory concentrations of ciprofloxacin.
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inflammatory response leads to the so-called chronic phenotype.
Chronic phenotype occurs when bacteria become well-adapted to
the conditions of the respiratory tract of CF patients and,
therefore, persists in spite of antibiotic therapy.
RESULTS
CIP exposure selects for CIP-resistant variants with prolonged lag
phase
Growth curves of 92 CIP-resistant isolates (47 WT PAO1 and
45 ΔkatA) representing 57 isolates recovered from CIP-evolved
populations and 35 isolates recovered from CTRL-evolved
populations were analyzed.
Three parameters of bacterial growth were calculated: max-
imum growth density, doubling time, and time to initiation of the
exponential phase (lag time).
CIP-resistant colonies from CIP-evolution had significantly
extended lag phase compared to CTRL (p= 0.002). For WT
PAO1, the lag phase (median (range) in h) was 5.36 (3.5–13) vs.
3.5 (3.5–9.7) while for ΔkatA it was 6.84 (4.2–14) vs. 5.2 (4.8–6.5)
(Fig. 2). The extended lag phase was more frequent in ΔkatA
colonies compared to WT PAO1, and it occurred also in some of
the CTRL colonies suggesting adaptation to growth in media
during the evolution experiment.
For CIP-resistant colonies of the WT PAO1, a statistically
significant (p= 0.0007) increase in the doubling time was found
for the colonies isolates from CIP evolved compared to CTRL
populations. The doubling time (median (range) in min) was 97.5
(71–893) vs. 69 (69–104). This was not observed for colonies
isolated from the planktonic evolution experiment
The fitness cost of CIP-resistance development
To determine the fitness cost of the CIP resistance, the fitness
index (FI) of 42 CIP-resistant colonies (24 colonies from CIP-
evolved populations and 18 colonies from CTRL-evolved popula-
tions) (Supplementary Table 1) were investigated in competition
experiments started at ratio 1:1 between the evolved CIP-resistant
and the ancestor colonies in both planktonic and colony-biofilm
cultures. The competition in colony-biofilm cultures was con-
ducted in the presence and absence of 0.1 mg/L CIP.
The FI was expressed as the ratio between the doubling- time of
the CIP-resistant colony and the ancestor colony after 24 h
incubation (see Supplementary methods).
In planktonic competition studies, the CIP-resistant colonies
showed decreased fitness compared to the WT ancestors (FI < 1),
with the exception of CIP_Pl_10, CIP_Pl_11, and CIP_Pl_14. The
highest fitness cost was observed for the CIP-resistant colonies
isolated from the planktonic evolution of ΔkatA and the lowest for
CIP-resistant colonies isolated from planktonic evolution of PAO1.
An inverse correlation (R2= 0.53) between the lag time and the
planktonic FI was observed: the shorter the lag time, the better the
fitness (Fig. 3a).
The FI in a 24 h colony-biofilm without exposure or with 24 h
exposure to 0.1 mg/L CIP are shown in Supplementary Table 2. In
colony-biofilm competition studies, few CIP-resistant isolates were
identified in the mixed 48 h biofilm population. However, this was
dramatically changed when a 24 h-old biofilm was exposed to
0.1 mg/L ciprofloxacin for 24 h. In the latter case, the CIP-resistant
colonies had a significant (p= 0.0005), growth advantage
compared to ancestor colonies (Fig. 3b) (Supplementary Table 2).
CIP exposure selects for CIP-resistant colonies with impaired
twitching but maintained swarming motility
The swimming, swarming and twitching motility of 92 CIP-
resistant isolates were analyzed (57 CIP and 35 CTRL) (Fig. 4).
No significant difference in swimming motility between the CIP
and CTRL isolates was observed, though for both groups the CIP-
resistant isolates were impaired in swimming compared to
ancestor colonies.
CIP-resistant colonies from CTRL-evolved populations had
significantly lower swarming motility (p= 0.0001) and higher
twitching motility (p= 0.03) compared to CIP-evolved populations.
Cross-resistance to beta-lactam antibiotics
The MIC of ciprofloxacin, ceftazidime, aztreonam, meropenem,
tobramycin, and colistin in CIP-resistant (24 colonies from CIP-
evolved populations and 18 colonies from CTRL-evolved popula-
tions) were determined and are presented in Fig. 5a, b and
Supplementary Table 3.
The level of resistance was higher in the CIP-resistant colonies
from CIP-exposed populations compared to CTRL population and
simultaneous resistance to beta-lactams such as aztreonam and
ceftazidime was observed, in many cases with MICs above the
clinically resistance breakpoints (Supplementary Table 2). How-
ever, CIP-resistant isolates showed decreased MICs to tobramycin
and colistin antibiotics.
No correlations between the CIP MIC levels and the fitness
index, lag period or doubling time were observed.
Growth of resistant subpopulations in the inhibition zone of the
antibiotic strip were observed for all the CIP-resistant colonies with
hypermutable phenotype (Supplementary Table 3) but also in
other populations of single CIP-resistant colonies suggesting a
hetero-resistant phenotype, especially to meropenem.
Genomic mutations of the evolved-resistant isolates that could
explain the observed phenotypes
To elucidate the genetic mechanisms underlying the antibiotic
resistance and the evolved phenotypes in the evolved CIP-
resistant colonies, we have sequenced 24 CIP-resistant colonies
recovered from CIP-evolved populations (16 colonies isolated
from biofilm populations and 8 colonies isolated from planktonic
populations) and 18 CIP-resistant colonies recovered from CTRL-
evolved populations (11 colonies isolated from biofilm popula-
tions and 7 colonies isolated from planktonic populations) for
both WT PAO1 and ΔkatA. The genomic DNA of original ancestors
PAO1 and ΔkatA were sequenced as well. The identification and
phenotypes of the sequenced colonies are presented in Supple-
mentary Tables 1 and 2a, b.
Mutations with frequencies above 80% were prioritized for
determining the number of mutations and calculating the ratio
between nonsynonymous and synonymous mutations dN/dS
Fig. 2 Box and whisker plots representing the median, 25, 75, and
90 centiles of the lag time (h) of CIP-resistant colonies isolated
from evolution under CIP exposure (CIP) and without antibiotic
exposure (CTRL). a Significant longer lag phase was observed in
CIP-evolved compared to CTRL-evolved PAO1 colonies (in red) (p=
0.002) and ΔkatA (in blue) (p= 0.002). The lag phase of the ancestor
colonies is represented by the red (PAO1) and the blue (ΔkatA) dot.
Mann–Whitney test for nonparametric data was used to compare
the different groups.
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(Table 1). In CIP-evolved populations the ratio dN/dS is higher than
in CTRL populations suggesting a positive selection. To get more
insights into the mutational landscape, we also considered
mutations with frequencies below 80% and higher than 10%.
(Supplementary Data Set).
Gene mutations which are repeatedly observed after indepen-
dent exposures to a condition provide strong evidence for
adaptive evolution. To identify common genes that were mutated
under evolution at sub-MIC CIP, we focused on genes which were
recurrently mutated in several of the CIP-resistant colonies16. A
map showing the presence or absence of the mutated genes in
different functional classes related to the observed phenotypic
shifts is presented in Fig. 6.
Mutations in CIP-resistant colonies from CIP-evolved populations
Mutations in antibiotic resistance determinants. Common evolu-
tionary trajectories among CIP-resistant colonies leading to
resistance to CIP were observed.
In CIP-resistant colonies from WT PAO1 planktonic populations,
simultaneous mutations in gyrase gyrA and efflux-pump regulators
of MexAB-OprM (mexR, nalC, and nalD) at high frequencies might
explain the high-MIC values to ciprofloxacin. In addition, in one of
the colonies CIP_Pl_10, mutations in PA3228 gene that encodes
for a putative ATP-binding/permease fusion ABC transporter that
may function as a multidrug transporter was observed with high
frequencies (>80%).
In the CIP-resistant colonies from WT PAO1 biofilm populations,
nfxB gene, a negative regulator of efflux-pump MexCD-OprJ was
repeatedly mutated as well as other efflux-pump regulator genes,
such as mexR and mexS, at high frequencies. The MIC ciprofloxacin
levels in these colonies are lower than in planktonic colonies with
the exception of CIP_BF_5 (Supplementary Tables 1, 3) with high
MIC of CIP of 32mg/L in which an additional mutation in PA3228
gene encoding an ABC transporter was observed at low frequencies.
In CIP-resistant colonies from ΔkatA planktonic populations,
simultaneous mutations in mexR or nalD at high frequencies and
parC at low frequencies can explain the CIP-resistant phenotype. In
one colony CIP_Pl_25 (Supplementary Tables 1, 3) with a
subpopulation with MIC to ciprofloxacin of 6mg/L, an additional
mutation in PA3228 was also identified at low frequencies.
In CIP-resistant colonies of ΔkatA biofilm populations, three
colonies (CIP_BF_15, CIP_BF_16, and CIP_BF_18) had a 28 nucleotide
insertion in mutL causing a hypermutable phenotype (Supplemen-
tary Data Set). In the hypermutable colonies simultaneous mutations
in gyrase gyrB, parC, as well as efflux-pump regulators such as nfxB
at high frequencies might explain the high-MIC values to
ciprofloxacin. In one of the colonies CIP_BF_15, mutations in the
ABC transporter PA3228 gene were found at high frequencies
(>80%).
A list of mutated genes that might explain for the observed cross-
resistance of CIP-resistant colonies to beta-lactams, and especially
aztreonam is presented in Fig. 6.
Fig. 3 Relative fitness (Fitness index) of the evolved CIP-resistant isolates compared to the ancestor colonies. a An Inverse correlation
(R2= 0.53) between the lag time and the planktonic fitness index (FI) was observed. b CIP-resistant colonies had a significant (p= 0.0005)
better biofilm FI in CIP-exposed biofilms compared to unexposed. Wilcoxon matched-pairs signed ranks was used as statistical test.
Fig. 4 Motility of CIP-resistant colonies Plots representing the
swimming (squares), swarming (triangles) and twitching (dots)
motilities (median, and the ranges) in (mm) of CIP-resistant
colonies isolated from evolution experiments under exposure to
CIP (CIP) or without CIP exposure (CTRL). For comparisons, the
motilities of the WT PAO1 are presented by black symbols in the
figure. A significant lower twitching motility (p= 0.03) and higher
swarming motility (p= 0.0001) was observed in CIP-resistant
colonies isolated from CIP compared to and CTRL biofilms.
Mann–Whitney test was used for statistical analysis.
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In CIP-resistant colonies isolated from evolution under CIP
exposure, mutations in efflux pumps regulators (nfxB, nalC, nalD,
and mexR) were identified. These mutations cause upregulation of
the MexCD-OprJ and MexAB-OprM pumps which, besides cipro-
floxacin, also accommodate beta-lactams. Interestingly, in addition
we detected mutations in genes encoding for proteins involved in
cell division (the divisome) (for example, ftsI, ftsZ, and murG),
penicillin-binding protein pbpAC and amp genes involved in the
regulation of AmpC beta-lactamase (Fig. 6).
Mutations in genes of metabolic pathways. In CIP-resistant
colonies there were mutations at frequencies higher than 80%
in different genes related to the arginine metabolism and
transport such as argS and aotQ in colonies CIP_BF_4, CIP_BF_8
of the WT PAO1 and CIP_BF_15 of ΔkatA. While at frequencies
lower than 80%, mutations in aruB, aruD, aruI, speA, argC, aotJ and
hutE were repeatedly detected in CIP-resistant colonies of the WT
PAO1 and ΔkatA CIP-resistant colonies (Fig. 6).
We have also detected mutations in genes related to the
metabolism and transport of polyamines, as arginine is one of the
precursors for polyamine synthesis. Mutated genes, such as aphA,
potA, and potB were detected in several colonies (Fig. 6).
In CIP-resistant colonies isolated from biofilm, mutations in
PA1300 encoding for σ factor 70 and in rpoN encoding for σ factor
54 were observed repeatedly and this might correlate to the
observed prolonged lag phase observed in these colonies.
In addition, mutations in rpoS gene that codes for stress
response regulator RpoS were detected in five CIP-resistant
colonies (colonies no. CIP_BF_3, CIP_BF_5, CIP_BF_6, and
CIP_Pl_26). It is noteworthy that these mutations are not present
in WT CTRL-resistant colonies. These mutations might explain the
increased doubling time of the CIP-resistant colonies.
In some of the CIP-resistant colonies, mutations in genes related
to TCA cycle were observed. In colonies no. CIP_BF_7, CIP_BF_21,
and CIP_Pl_25, the sdhA gene that encodes succinate dehydro-
genase was mutated at frequencies higher than 80%. In addition,
poxB and PA2290 genes that encodes pyruvate and glucose
dehydrogenases were also found to be mutated.
In the ΔkatA-hypermutable CIP-resistant colonies, the genes
related to iron storage and transport were mutated such as fecA,
Fig. 5 Cross-resistance and collateral sensitivity to different antibiotics. Heat map showing the changes in the resistance levels to six
classes of antibiotics. Results shown are the log2 fold change in the minimum inhibitory concentrations (MIC) (mg/L) in the evolved CIP-
resistant isolates compared to the sensitive ancestral strain. a The relative changes in the MIC levels in CIP-resistant isolates recovered from
CIP-evolved populations. b The relative changes in the MIC levels in CIP-resistant isolates recovered from CTRL-evolved populations. CIP
ciprofloxacin, CEF ceftazidime, MER meropenem, AZT aztreonam, TOB tobramycin, COL colistin.
Table 1. The types of mutations (number and % of total number of mutations) in CIP and CTRL-resistant colonies in WT PAO1 and ΔkatA biofilm and
planktonic (PL) P. aeruginosa.
Transitions Transversions Insertions/deletions Inversions/duplications Total number of mutations dN/dS
CIP-resistant colonies
PAO1_biofilm 6 (24%) 3 (12%) 13 (52%) 3 (12%) 25 2.7
PAO1_PL 5 (18%) 6 (21%) 13 (46%) 4 (14%) 28 1.6
ΔkatA_biofilm 157 (78%) 3 (1.5%) 43 (21%) 3 (1%) 206 1.5
ΔkatA_PL 1 (8%) 3 (25%) 8 (89%) 0 12 0.9
CTRL-resistant colonies
PAO1_biofilm 1 (8%) 5 (42%) 6 (50%) 0 12 2
PAO1_PL 3 (18%) 0 7 (41%) 7 (41%) 17 1
ΔkatA_biofilm 1 (6%) 1 (6%) 14 (82%) 1 (6%) 17 0.1
ΔkatA_PL 3 (38%) 0 5 (63%) 0 8 0.4
The ratio between the nonsynonymous/synonymous mutations (dN/dS) is presented.
M.N. Ahmed et al.
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fecI, hasR, and PA2911 that encodes tonB dependent receptors at
frequencies above 80% (Supplementary Data Set).
Mutations in CIP-resistant colonies from CTRL-evolved populations.
Surprisingly, in CIP-resistant colonies from CTRL populations, nfxB
gene was also frequently mutated in the majority of CTRL-resistant
colonies showing that population with decreased susceptibility to
CIP can arise in biofilm and planktonic growth modes without
exposure to antibiotics.
Quorum-sensing genes such as lasR and prmC were mutated in
CTRL –resistant colonies of both WT PAO1 and ΔkatA in colonies
CTRL_BF_3, CTRL_BF_4, CTRL_BF_5, CTRL_Pl_17, and CTRL_Pl_18.
This might explain the impaired swarming motility observed in
CTRL CIP-resistant colonies compared to CIP-exposed colonies.
Mutations in genes considered patho-adaptive in chronic infections.
We queried if the mutated genes identified during in vitro
experimental evolution were of relevance for the in vivo evolution,
and we looked for common genes with the patho-adaptive genes
found to be mutated in several P. aeruginosa isolates from chronic
lung infections of patients with CF17,18. A list of common genes
encountered during in vivo and in vitro evolution is presented in
Supplementary Table 4 and Fig. 7.
DISCUSSION
Extensive phenotypic and genotypic changes compared to the
ancestor colonies have been observed in the CIP-resistant colonies
isolated from P. aeruginosa WT and ΔkatA biofilm and planktonic
Fig. 6 A distribution map of the mutated genes belonging to different functional categories in the CIP-resistant colonies isolated under
different conditions. The blue boxes indicate the genes with nonsynonymous mutations identified in the individual CIP-resistant colonies
recovered from CIP- and CTRL-evolved biofilm and planktonic (PLA) populations. The identity number of the colonies is shown in
Supplementary Table 1.
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evolution experiments in the presence of sub-MIC concentration
of CIP. The evolution in the presence of subinhibitory concentra-
tions of CIP selected for CIP-resistant mutants with distinct
phenotypes compared to those isolated from CTRL populations.
We show that pathways of CIP-resistance development depend
on of the bacterial life-style. High-level CIP-resistant mutants were
isolated especially from evolution in planktonic populations while
low-level CIP-resistant mutants were isolated from evolution in
biofilm. The genetic basis for the two distinct phenotypes were
simultaneous mutations in quinolone resistance determinants
gyrA, parC, and efflux-pump regulators in high CIP-resistant
mutants from planktonic populations as repeatedly pub-
lished9,14,15,19 and mutations in efflux-pump regulators for CIP-
resistant mutants evolved in biofilms. Similar observations have
been recently published in Acinetobacter baumanii20 suggesting
that this is a general characteristic of evolution in biofilms.
Low-level CIP-resistant mutants due to mutations in mexZ, a
negative regulator of MexXY-OprM efflux-pump associated to
active efflux of aminoglycosides and ciprofloxacin were reported
in CF P. aeruginosa isolates from the initial phase of the chronic
lung infection, suggesting that this may contribute to in vivo
persistence21.
Association between resistance to CIP and beta-lactams was
observed in this study (Supplementary Table 3). Here, we detected
many genes especially involved with cell division and TCA cycle
responsible for high resistance to ceftazidime and aztreonam
antibiotics, confirming previous findings22,23 (Figs 5 and 6). Cross-
resistance between CIP and beta-lactam antibiotics was also found
in the planktonic experimental evolution study of P. aeruginosa9.
In addition, our data show that CIP-resistant colonies displayed
collateral increased sensitivity to both tobramycin and colistin.
Previous studies24 showed that CIP-resistant isolates of P.
aeruginosa are susceptible to aminoglycosides. This might be
explained by the mutations in nfxB which has been shown to
correlate to decreased activity of the MexXY-OprM and collateral
sensitivity to aminoglycosides25. However, the minimal increase in
the sensitivity to aminoglycosides and colistin of nfxB mutants has
probably no or limited impact on the clinical efficacy of the
treatment with these antibiotics since clinical treatments use
concentrations that are far above these MICs. An extended lag
phase and a reduction in max growth in LB were observed in CIP-
evolved colonies. This is in accordance to recent studies
investigating the metabolic functionality of experimentally
evolved antibiotic-resistant P. aeruginosa which showed that CIP-
evolved lineages exhibited longer lag phases and longer doubling
times26.
The importance of the lag phase in the bacterial response to
antibiotics has been previously shown by Fridman et al.27, who
reported that “tolerance by lag” allows bacteria to survive under
high antibiotic concentrations, and may facilitate the subsequent
development of resistance. However, in our studies, the extension
of the lag phase is not an adaptive response to antibiotics as the
growth curves of the CIP-resistant colonies were conducted in the
absence of the antibiotic, and the CIP-resistant colonies have been
passed twice in antibiotic-free media after isolation from the
population analysis plates. The mutations identified in the
different metabolic pathways and RNA polymerase sigma factors
might explain this phenotype.
Competition experiments in planktonic cultures showed that
CIP resistance was associated with a fitness cost. However, in
biofilm competition studies the resistant colonies persisted as a
very small subpopulation and overgrew the ancestor colony in the
presence of 0.1 mg/L CIP. Persistence of CIP-resistant colonies in
biofilms in spite of their fitness cost suggest that growth rates are
less important for survival in this mode of growth which probably
allows maintenance of resistance for longer period of time in the
absence of selective pressure.
Swarming, which is QS regulated28,29, was maintained in CIP-
resistant colonies evolved under selection with sub-MIC CIP while
CTRL CIP-resistant colonies lost the swarming. The mutations in
the QS genes found in CTRL CIP-resistant colonies can explain this
phenotype. This is in accordance with a recent published study
confirming the lack of selection of QS mutants (lasR) during
evolution experiments in the presence of antibiotics30.We have
previously shown in planktonic experimental evolution studies
that higher levels of QS molecules in P. aeruginosa populations
evolved under sub-MIC ciprofloxacin compared to CTRL10.
It has been shown that swarming P. aeruginosa exerts adaptive
resistance to a number of antibiotics, including CIP, which might
explain the maintenance of the swarming motility during
evolution in the presence of CIP28.
The loss of twitching motility is correlated to the frequent
mutations in pil genes encoding for type IV pili identified in CIP-
resistant colonies. The association between CIP resistance and
Fig. 7 Common genes mutated in evolved P. aeruginosa isolates under in vivo and in vitro conditions. This diagram shows the mutated
genes in the evolved-resistant isolates recovered from the in vitro experimental evolution of P. aeruginosa that are correlated with the patho-
adaptive genes detected in naturally evolved clinical isolates inside the CF lungs18,33,39,43. The genes that are only mutated in CIP-evolved
colonies are in black, those mutated only in CTRL-evolved colonies are highlighted in red while the genes that are mutated in both CTRL- and
CIP-evolved colonies are highlighted in blue. The threshold of the frequency of the mutated genes in evolved isolates is higher than 10%.
M.N. Ahmed et al.
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mutations in pil genes has been reported by other groups but the
reason for this association is not completely clear24.
Mutations in genes responsible for the catabolism of arginine such
as aruL involved in the arginine decarboxylase and arcA involved in
the arginine deaminase catabolic pathways were identified. Impair-
ment of these pathways promotes the utilization of arginine by nitric
oxide synthase to convert it to nitric oxide31,32. Nitric oxide will
promote anaerobic respiration, and this is in agreement with
previous studies that showed that anaerobic respiration is promoted
in P. aeruginosa under CIP treatment10,33. Nitric oxide has been
shown to be involved in the biofilm disruption34, but if this would
occur as a consequence of the metabolic rewiring in CIP-treated
biofilms remains to be investigated.
Antibiotic-resistant P. aeruginosa mutants overexpressing efflux
pumps were shown to rewire their metabolism to avoid fitness cost
including increased expression of the anaerobic nitrate respiratory
chain when cells are growing under aerobic conditions35.
In accordance with the metabolic rewiring in the presence of
ciprofloxacin, we have detected mutations in the enzymes
involved in the TCA cycle in CIP-resistant colonies. This is in
agreement with studies5 showing that mutants with impaired
activity of TCA cycle enzymes were more tolerant to antibiotics
due to decreased levels of bactericidal hydroxyl-radicals36.
Interestingly, mutations in the enzymes of the TCA cycle have
been reported in clinical P. aeruginosa isolates that have evolved
in the lung of CF patients37 and associated to the impaired
catabolic capacity of the isolates. We have previously reported
that metabolic reduction is a common adaptive trait of the P.
aeruginosa nonmucoid isolates in the CF lung38 which has
probably an impact on the persistence of the bacteria in the
lung, in spite of the antibiotic treatment.
In addition, RNA polymerase σ54 (rpoN) and σS (rpoS) were found
to be mutated in some CIP-biofilm resistant colonies and ΔkatA
planktonic-resistant colonies and associated to impaired growth of
the isolates. However, mutations in these genes were not detected
in WT PAO1 planktonic-CIP and either of the CTRL-resistant
colonies. Interestingly, rpoN mutants were found in P. aeruginosa
from chronically infected patients17,39.
A comparison of the identified mutated genes in CIP-resistant
colonies from in vitro-evolved populations with a list of patho-
adaptive genes found to be mutated in several P. aeruginosa
isolates from chronic lung infections of patients with CF17,18
revealed a large degree of overlap (Fig. 7; Supplementary Table 4)
suggesting the important role played by antibiotic exposure of
biofilm-growing bacteria in shaping the adaptation in vivo. This is
in agreement with previous published results showing that,
in vitro evolution can be used to predict in vivo adaptive changes
in the presence of antibiotics24. However, some patho-adaptive
genes, for example those involved in conversion to mucoidity and
biofilm formation (mucA, algU, algG, pelA, and rbd A) were only
mutated in clinical isolates suggesting the role of the immune
system in the selection of these phenotypes, in accordance to our
previous publication40.
In the future, supplementation of the present results with gene
expression data will improve the understanding of evolution
processes in biofilms.
In conclusion, our data on the phenotypic and mutagenic
evolution in P. aeruginosa biofilms support the mutagenic
potential of CIP at subinhibitory concentrations41. Mutations in
CIP-resistance determinants were associated with mutations
conferring phenotypes supporting a general survival advantage
in the presence of antibiotics, as they were affecting some of the
common mechanisms of action described for antibiotics, such as
switch of the metabolic pathway to anaerobic respiration or
affecting the TCA cycle. Phenotypes such as increased lag phases
will also impair the effect of other antibacterial agents, while loss
of twitching might impair biofilm dispersal42. Overall, our data
show that CIP-resistant mutants acquire several other mutations
that might confer survival advantages during antibiotic treatment
of biofilms.
METHODS
Strains
The wild-type (WT) P. aeruginosa PAO1 and its catalase mutant (ΔkatA)
(MIC CIP= 0.125 µg/ml) have been used previously to start biofilm and
planktonic evolution experiments in the presence of 0.1 mg/L ciprofloxacin
(CIP) or without selection pressure (CTRL) for seven passages, as previously
published14,15. The evolved populations were plated on LB plates
containing ciprofloxacin (0.5, 1, and 2mg/L) (population analysis) and
three colonies from the plates with the highest ciprofloxacin concentration
which allowed growth were isolated, passed twice on antibiotic-free media
and stored at −80 oC for further analysis (see Fig. 1a). CIP-resistant colonies
isolated after the last passage of the biofilm and planktonic evolution
experiments were used for further investigations in this study.
For growth curves and motility assays all the available CIP-resistant
colonies from CIP and CTRL evolution experiments, which are in total 92
isolates, were investigated.
For whole-genome sequencing, susceptibility testing to antipseudomonal
antibiotics and fitness cost determinations in both planktonic and biofilm
growth, a total of 42 colonies were investigated; 24 colonies from CIP-
evolved populations (16 colonies isolated from biofilm populations and 8
colonies isolated from planktonic populations) and 18 colonies from CTRL-
evolved populations (11 colonies isolated from biofilm populations and 7
colonies isolated from planktonic populations). The selection was randomly
done and aimed at including colonies representing the different replicate
lineages (Supplementary Table 1). Four of the ΔkatA CIP-resistant colonies
had hypermutable phenotype, as indicated in Supplementary Table 1.
Phenotypic characterizations
Growth curves, MIC determinations, fitness cost determination in
planktonic and biofilm cultures and motilities (swimming, swarming, and
twitching) were performed, as described in Supplementary methods.
WGS and analysis
The whole-genome sequencing was performed for 42 CIP-resistant
colonies (24 isolated from CIP-evolved population and 18 from CTRL-
evolved populations) as well as for WT PAO1 and ΔkatA ancestor colonies.
Genomic DNA was extracted from the colonies using Gentra puregene
yeast/bacteria DNA purification kit (Qiagen). The DNA was prepared for
sequencing using the Illumina TruSeq DNA Nano kit and sequenced on an
Illumina MiSeq yielding a coverage of approximately 120×. Sequencing
reads were mapped to the reference genome of P. aeruginosa PAO1
(GenBank accession. NC_002516), and single and multiple nucleotide
variants (SNVs and MNVs) were called using CLC genomic workbench
(Qiagen). Large indels and structural variants were also detected using
using CLC genomic workbench. Mutations present in the CIP-resistant
colonies were filtered out from the genome of the sequenced WT PAO1
and ΔkatA ancestor colonies using customized Linux and AWK scripts. R
(version 3.2.5) was used for further statistical analysis of the mutations
detected in colonies and all mutations occurring in >10% of the reads and
at least 10 unique reads were included in the analysis.
The Pseudomonas Genome Database was used for gene function
analysis. dN/dS, the ratio of the rate of nonsynonymous substitutions (dN)
to the rate of the synonymous substitutions (dS), was calculated as a
measure of the selection pressure acting on the protein-coding genome, as
previously described, assuming that 25% of all single-nucleotide poly-
morphisms (SNP) result in synonymous changes33. dN/dS is expected to be
>1 if natural selection promotes changes in protein sequences and <1 if
natural selection suppresses changes.
Statistical analysis
Graphs and statistical analysis were performed using GraphPad Prism 7,
Statview software and R (version 3.2.5). Student t-test and Mann–Whitney
for nonparametric were used for comparisons among resistant isolates for
growth rates and motilities (comparing CIP populations to CTRL
populations and CIP-biofilm populations to CIP planktonic populations).
The differences were considered significant when the p value was ≤0.05.
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Reporting summary
Further information on experimental design is available in the Nature
Research Reporting Summary linked to this article.
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